Sept 25 (Reuters) – Shares in Swedish drug-delivery company Nanexa more than doubled their value in early Friday trading after it signed a global licensing deal with Novo Nordisk worth up to about
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
MILAN, Sept 25 (Reuters) - Italy's Treasury said on Friday it would offer a new…
By Stella Qiu SYDNEY, Sept 25 (Reuters) - Asian shares held their nerve on Friday…
KAZAKHSTAN DETAINS FIRST DEPUTY NAVY COMMANDER, FOUR UNIT COMMANDERS FOLLOWING MILITARY DEATHS DURING EXERCISES -…
(Updates in news bulletin format; Adds more context and quotes from bullet 1 onwards) JOHANNESBURG,…
SPORTS - DAILY OUTLOOK - FRIDAY SEPTEMBER 25, 2026 . EXPECTED: SOCCER-COLOMBIA/CHAPECOENSE - Brazilian Club…
Sept 24 (Reuters) - Anthropic is asking shareholders to approve a new corporate structure that…